Oireachtas Joint and Select Committees
Wednesday, 12 July 2017
Joint Oireachtas Committee on Health
Evaluating Orphan Drugs: Discussion
9:00 am
Mr. Shaun Flanagan:
It is a statement of fact - the NCPE website report is there - that Entresto is on the NCPE website as meeting the cost-effectiveness test, if one accepts that the cost-effectiveness test has a result of €45,000 per quality-adjusted life year. If that is the Deputy's definition of cost effectiveness, it is cost-effective.
No comments